Tagged with

Office for the Strategic Coordination of Health Research (OSCHR) It are exciting times for the UK, with the public healthcare system undergoing so many changes. The Office of Life Sciences (OLS) and the Therapeutic Capability Clusters are just some examples of the new way forward. According to you, what are the factors that drove Government to pursue such drastic…

Pfizer UK As part of a panel discussion with Claudia Hammond of the BBC last year, you commented on the fairly poor relationship between the NHS and industry, and the need to build greater trust on both sides in order to improve the uptake of new products and foster innovation in the…

British Generic Manufacturers Association (BGMA) Together with Germany, the UK the highest generic penetration rate in Europe. Since you have been with the association since 1995 and obviously saw the great emergence of the generic medicines, can you please explain the success of generic medicines in the UK? The important aspect about the UK, which…

Association of the British Pharmaceutical Industry (ABPI) What are the priorities on your agenda as the new head of ABPI considering the successes and difficulties the association has experienced in the past? If you look at the recent history of the pharmaceutical industry in the UK, perhaps one of the areas that we have been most successful…

AstraZeneca UK AstraZeneca reported decrease in its global revenue for the first half of 2011 mostly due to adverse market conditions in the US. In this context, how has the company been performing in its home market and what will be driving your growth in the UK? Our financial results are in…

The UK has got around half of the public biotech companies and 21% of all entrepreneurial bioscience companies in Europe. From your perspective, can you explain what the key success factors are that made the UK bioscience industry one of the most advanced in the world? First and foremost, the…

Promega Netherlands Promega is a truly global company with a vast international presence. What would you say is the strategic importance that the Benelux affiliate has assumed within Promega’s global network? Promega Benelux is actually the first branch office that was established outside of the US, so the company’s experience in bringing…

Proprietary Association of Great Britain (PAGB) Thank you for having us today! You have been chief executive of the Association since 1990 and obviously observed the evolution of the OTC market from close by. From your experience, can you please explain our readers how you have seen the OTC market evolving here in the UK? From…

  Despite a population of 95 million and a growing economy, the Philippine pharmaceutical industry has been largely overlooked in the past–but things are about to change. The industry has been quite radically reshaped in the last year, following the approval of the Universally Accessible Cheaper and Quality Medicines Act,…

Medichem (Malta) Medichem began production at its plant in Malta in 2006. Can you give us a brief overview of the facilities, and of the importance of the subsidiary to Corporación Medichem as a group? Medichem was set up as a state-of-the-art facility for the manufacture of active pharmaceutical ingredients (APIs) in…

Ministry of Health (MOH) of Malaysia Would you begin by giving our readers a brief overview of the recent changes in the Ministry of Health’s focus? After Prime Minister Najib changed Malaysia’s economic policy from the ‘New Economic Policy’ to the ‘Economic Transformation Programme’ there has been a paradigm shift in the ministry’s focus. The government…

Malaysian Biotechnology Information Centre (MABIC) How would you describe MABIC today and the way that it has evolved since its creation in 2000? The Malaysian Biotech Information Centre or MABIC is an NGO and part of the ISAAA. MABIC’s central objective is to disseminate fact-based, science-based information about biotechnology to the public. The word biotechnology…